Insulet Corporation (NASDAQ:PODD) is one of the best growth stocks to buy in 2026. On December 18, Truist lowered the firm’s ...

Fintel reports that on December 18, 2025, Truist Securities maintained coverage of Insulet (NasdaqGS:PODD) with a Buy ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...

Fintel reports that on December 16, 2025, Evercore ISI Group initiated coverage of Insulet (NasdaqGS:PODD) with a Outperform recommendation. Analyst Price Forecast Suggests 33.61% Upside As of ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth ...

In a report released on December 16, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Insulet, with a price target of $380.00. The company’s shares closed yesterday at $288.73.

Insulet Corporation (NASDAQ:PODD) develops, manufactures, and sells insulin delivery systems for people with ...

In a report released today, Patrick Wood from Morgan Stanley maintained a Buy rating on Insulet, with a price target of $370.00. Claim 60% off TipRanks Premium for data-backed insights and research ...

Despite record beef prices linked to a country-wide cattle shortage, long lines formed at butcher shops Tuesday. TMJ4 spoke with some in line to hear how the price hike is affecting their wallets.